Tag: avinger

August 30, 2018

Avinger Announces 510(k) Filing of Pantheris Small Vessel Device

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the Company submitted a new...
August 23, 2018

Avinger Completes Enrollment in SCAN Clinical Study

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has completed enrollment...
July 12, 2018

Avinger Announces Pricing of $3.55 Million Registered Direct Offering

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into...